iBio, Inc.

NASDAQ:IBIO

Biotechnology

Healthcare
$0.80 +0.00%

+$0.00 today

Market cap
$56.44M
Beta
1.29
P/E (TTM)
-3.6
EPS (TTM)
-$0.32
52W Low $0.78High $3.82

Volume 0.43M

Average 0.81M

Balance Sheet

Inspect the capital base behind the business.

Assets

$99.11M

FY 2026 · Annual

+327.5% YoY

Liabilities

$13.40M

FY 2026 · Annual

+61.3% YoY

Equity

$85.71M

FY 2026 · Annual

+476.0% YoY

Balance Sheet

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Cash & Equivalents22.68M7.33M14.21M8.58M56.4M
Short-term Investments10.85M00031.64M
Net Receivables6.1M204K713K105K1.1M
Inventory3.9M0000
Other Current Assets018.73M749K1.03M3.08M
Total Current Assets45.07M26.26M15.67M9.72M92.22M
Property, Plant & Equipment (Net)41.76M7.55M6.37M5.28M4.75M
Goodwill00000
Intangible Assets4.85M5.39M5.37M6.85M1.83M
Long-term Investments7.63M1.96M1.3M1.31M228K
Tax Assets(7.63M)0000
Other Non-current Assets7.73M50K26K26K83K
Total Non-current Assets54.34M14.95M13.06M13.46M6.89M
Total Assets99.41M41.21M28.73M23.19M99.11M
Account Payables4.26M1.85M358K2.19M4.42M
Short-term Debt22.16M13.6M218K766K0
Tax Payables284K268K000
Deferred Revenue100K0200K1.2M0
Other Current Liabilities754K2.52M761K876K6.78M
Total Current Liabilities30.44M21.58M3.84M6.11M11.75M
Long-term Debt00766K00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.97M768K63K00
Total Non-current Liabilities5.49M4.24M3.57M2.2M1.65M
Total Liabilities35.92M25.83M7.41M8.31M13.4M
Common Stock9K20K9K19K56K
Retained Earnings(223.93M)(288.94M)(313.85M)(332.22M)(365.27M)
Accumulated OCI(213K)000(45K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity63.49M15.38M21.32M14.88M85.71M
Total Debt25.77M17.07M4.46M3.51M2.2M
Net Debt3.09M9.75M(9.75M)(5.07M)(54.2M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$56.4M
Short-term Investments$31.6M
Receivables$1.1M
Other Current$3.1M
Total Current Assets$92.2M
PP&E (Net)$4.8M
Intangible Assets$1.8M
Long-term Investments$228.0K
Other Non-current$83.0K
Total Non-current Assets$6.9M
Total Assets$99.1M

Analysis

Selected assets total $99.1M for Latest. The largest visible component is Cash & Equivalents at $56.4M, about 56.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportOct 19, 2026
4Statement of changes in beneficial ownershipOct 15, 2026
4Statement of changes in beneficial ownershipOct 15, 2026

How much cash does IBIO have?

iBio, Inc. (IBIO) reported $56.40M in cash and equivalents in fiscal 2026.

How much debt does IBIO carry?

iBio, Inc. (IBIO) reported $2.20M of total debt, with net debt of -$54.20M.